144 related articles for article (PubMed ID: 36906905)
1. Human genetic and immunological determinants of SARS-CoV-2 and Epstein-Barr virus diseases in childhood: Insightful contrasts.
Pan-Hammarström Q; Casanova JL
J Intern Med; 2023 Aug; 294(2):127-144. PubMed ID: 36906905
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients.
Bernal KDE; Whitehurst CB
Virus Res; 2023 Sep; 334():199157. PubMed ID: 37364815
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus Lytic Replication Induces ACE2 Expression and Enhances SARS-CoV-2 Pseudotyped Virus Entry in Epithelial Cells.
Verma D; Church TM; Swaminathan S
J Virol; 2021 Jun; 95(13):e0019221. PubMed ID: 33853968
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus reactivation is not causative for post-COVID-19-syndrome in individuals with asymptomatic or mild SARS-CoV-2 disease course.
Hoeggerl AD; Nunhofer V; Lauth W; Badstuber N; Held N; Zimmermann G; Grabmer C; Weidner L; Jungbauer C; Lindlbauer N; Neureiter H; Ortner T; Flamm M; Osterbrink J; Rohde E; Laner-Plamberger S
BMC Infect Dis; 2023 Nov; 23(1):800. PubMed ID: 37968601
[TBL] [Abstract][Full Text] [Related]
5. Multiple Viral microRNAs Regulate Interferon Release and Signaling Early during Infection with Epstein-Barr Virus.
Bouvet M; Voigt S; Tagawa T; Albanese M; Chen YA; Chen Y; Fachko DN; Pich D; Göbel C; Skalsky RL; Hammerschmidt W
mBio; 2021 Mar; 12(2):. PubMed ID: 33785626
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the Relationship between SARS-CoV-2 and Cancer.
Costanzo M; De Giglio MAR; Roviello GN
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175509
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-Is it present in long COVID?
Ruiz-Pablos M; Paiva B; Zabaleta A
J Transl Med; 2023 Sep; 21(1):633. PubMed ID: 37718435
[TBL] [Abstract][Full Text] [Related]
8. [Reactivation of Epstein-Barr virus (
Solomay TV; Semenenko TA; Filatov NN; Vedunova SL; Lavrov VF; Smirnova DI; Gracheva AV; Faizuloev EB
Vopr Virusol; 2021 May; 66(2):152-161. PubMed ID: 33993685
[TBL] [Abstract][Full Text] [Related]
9. Successful Treatment of SARS-CoV-2 Vaccination-related Activation of Rheumatoid Arthritis with Positive Findings for Epstein-Barr Virus.
Nakamura H; Nagasawa Y; Kobayashi H; Tsukamoto M; Takayama T; Kitamura N
Intern Med; 2022 Jul; 61(13):2073-2076. PubMed ID: 35466171
[TBL] [Abstract][Full Text] [Related]
10. Functional SARS-CoV-2 cross-reactive CD4
Humbert M; Olofsson A; Wullimann D; Niessl J; Hodcroft EB; Cai C; Gao Y; Sohlberg E; Dyrdak R; Mikaeloff F; Neogi U; Albert J; Malmberg KJ; Lund-Johansen F; Aleman S; Björkhem-Bergman L; Jenmalm MC; Ljunggren HG; Buggert M; Karlsson AC
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2220320120. PubMed ID: 36917669
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and Epstein-Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection.
Rousseau BA; Bhaduri-McIntosh S
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112929
[TBL] [Abstract][Full Text] [Related]
12. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients.
Chen T; Song J; Liu H; Zheng H; Chen C
Sci Rep; 2021 May; 11(1):10902. PubMed ID: 34035353
[TBL] [Abstract][Full Text] [Related]
13. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
Sacco KA; Notarangelo LD; Delmonte OM
Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus Versus Novel Coronavirus-Induced Hemophagocytic Lymphohistocytosis: The Uncharted Waters.
Amir R; Kichloo A; Singh J; Bhanot R; Aljadah M; Kumar A; Albosta MS; Solanki S
J Investig Med High Impact Case Rep; 2020; 8():2324709620950107. PubMed ID: 32787459
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-specific cytokine-induced killer cells for treatment of Epstein-Barr virus-related malignant lymphoma.
Pfeffermann LM; Pfirrmann V; Huenecke S; Bremm M; Bonig H; Kvasnicka HM; Klingebiel T; Bader P; Rettinger E
Cytotherapy; 2018 Jun; 20(6):839-850. PubMed ID: 29754771
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation.
Xie Y; Cao S; Dong H; Lv H; Teng X; Zhang J; Wang T; Zhang X; Qin Y; Chai Y; Yang L; Liu J; Wang R
BMC Infect Dis; 2021 Sep; 21(1):955. PubMed ID: 34525962
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S; Fischer A
Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
[TBL] [Abstract][Full Text] [Related]
18. The first autopsy case of Epstein-Barr virus-positive marginal zone lymphoma that deteriorated after COVID-19 vaccination.
Wang Z; Muto R; Miyoshi H; Aoki M; Uesugi N; Murayama H; Masutani K; Hamasaki M
Pathol Int; 2024 Feb; 74(2):87-92. PubMed ID: 38116849
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus Coinfection in COVID-19.
Nadeem A; Suresh K; Awais H; Waseem S
J Investig Med High Impact Case Rep; 2021; 9():23247096211040626. PubMed ID: 34428954
[TBL] [Abstract][Full Text] [Related]
20. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19.
Abolhassani H; Delavari S; Landegren N; Shokri S; Bastard P; Du L; Zuo F; Hajebi R; Abolnezhadian F; Iranparast S; Modaresi M; Vosughimotlagh A; Salami F; Aranda-Guillén M; Cobat A; Marcotte H; Zhang SY; Zhang Q; Rezaei N; Casanova JL; Kämpe O; Hammarström L; Pan-Hammarström Q
J Allergy Clin Immunol; 2022 Nov; 150(5):1059-1073. PubMed ID: 36113674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
